#diabetes drugs

#diabetes drugs

Wegovy, Ozempic, and Mounjaro are weight loss and diabetes drugs that target regulatory pathways involved in obesity and diabetes.

The body produces natural versions of these drugs, known as incretin hormones, in the gut, and the trillions of gut microbes play a key role in regulating these hormones. [ more ]

Health disparities exist in the distribution of anti-obesity and diabetes drugs.

White people are four times more likely to receive a prescription than Black people.

Affordability and lack of access to medical care contribute to the unequal distribution. [ more ]